Last reviewed · How we verify
NCT06109025
Improvement of Motor Imaginative Ability Through Functional Electrical Stimulation
EARLY_PHASE1 trial testing FESIA GRASP in Electrode Site Reaction in 81 participants. Completed in 5 January 2024.
30 November 2023
Quick facts
| Lead sponsor | Universidad de Burgos |
|---|---|
| Phase | EARLY_PHASE1 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | basic science |
| Enrollment | 81 |
| Start date | 1 October 2023 |
| Primary completion | 30 November 2023 |
| Estimated completion | 5 January 2024 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- FESIA GRASP
- VIRTUAL REHAB
- GLOBUS ELITE
Conditions studied
- Electrode Site Reaction — all drugs for Electrode Site Reaction →
- Therapy, Directly Observed — all drugs for Therapy, Directly Observed →
Sponsor
Universidad de Burgos
Who can join
Adults 18 to 35, any sex, with Electrode Site Reaction or Therapy, Directly Observed. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a experimental, randomised, parallel-group, clinical study. A sample of university students will be divided into 4 groups, where one of them will act as a control group (no intervention), and the other three will undergo hand training with two different types of functional electrical stimulation devices and a final group will receive hand training with video games. Inter-group analyses will be performed before the start of the training (pre-intervention), after the end of the programme (post-intervention), and three weeks after the end of the programme (follow-up assessment). Intra-group analyses will also be carried out to check whether the training has led to an improvement in the quality of motor imagination, as well as an improvement in manual dexterity in each of the groups. In order to carry out the project, a collaboration agreement will be signed with the company FESIA TECHNOLOGY S.L, which will provide a FESIA GRASP device for the study, as well as the consumables (electrodes).
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Improvement of Motor Imagination and Manual Ability Through Virtual Reality and Selective and Nonselective Functional Electrical Stimulation: Protocol for a Randomized Controlled Trial.
Santamaría-Vázquez M, Ortiz-Huerta JH, Martín-Odriozola A, Saiz-Vazquez O. · · 2024 · PMID 39576986 · DOI 10.2196/63329
Verify or expand the search:
- PubMed search for NCT06109025
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Universidad de Burgos trials
Trials by the same sponsor.
- NCT07275996 — Neuromuscular and Multi-Omics Synergy of Combined Creatine × HMB Supplementation Plus Exercise to Improve Muscle Functio · NA · not yet recruiting
- NCT07213063 — Effects of Chronic Creatine and Beta-Hydroxy-Beta-Methylbutyrate Supplementation on Oxidative Stress, Inflammation, Musc · NA · recruiting
- NCT06909994 — Daily Living Activities in Young Adults With Cerebral Palsy · completed
- NCT06638775 — Functional Electrostimulation on the Upper Lip in Multiple Sclerosis · NA · not yet recruiting
- NCT05951439 — Effect of Creatine+HMB Supplementation in Physically Active Older Adults · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06109025 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidad de Burgos
- Last refreshed: 28 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06109025.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing